Literature DB >> 1106232

Dapsone metabolism in patients with dapsone-resistant leprosy.

R H Gelber, R J Rees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1106232     DOI： 10.4269/ajtmh.1975.24.963

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  7 in total

1.  Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria.

Authors:  F A Pieters; F Woonink; J Zuidema
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  [Experimental chemotherapy of leprosy].

Authors: 
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

3.  Experimental chemotherapy in leprosy.

Authors: 
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

Review 4.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

Review 5.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 6.  Clinical pharmacokinetic considerations in the treatment of patients with leprosy.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1989-06       Impact factor: 6.447

7.  Acetylation polymorphism and leprosy.

Authors:  L C Eze; A N Okpogba; A U Ogan
Journal:  Biochem Genet       Date:  1990-02       Impact factor: 1.890
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.